Safety and efficacy of ticagrelor and clopidogrel in primary percutaneous coronary intervention

scientific article published on 4 February 2016

Safety and efficacy of ticagrelor and clopidogrel in primary percutaneous coronary intervention is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1136/HEARTJNL-2015-308963
P698PubMed publication ID26848185

P50authorSteen E HustedQ114427074
Jérémie AbtanQ114427161
Lars WallentinQ6230815
Philippe Gabriel StegQ16027739
Hugo A. KatusQ27929168
Robert F. StoreyQ38590637
Robert A HarringtonQ62914910
Anne S HellkampQ63019876
Dominick AngiolilloQ72837721
Stefan JamesQ86735199
Matthijs In 't VeldQ87658927
Diego ArdissinoQ91861722
Phillip J SchulteQ114336769
Anders HimmelmannQ114371164
PLATO InvestigatorsQ114371185
P2093author name stringBernhard Meier
P2860cites workESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC)Q22242892
Universal definition of myocardial infarction: Kristian Thygesen, Joseph S. Alpert and Harvey D. White on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial InfarctionQ22242900
Ticagrelor versus clopidogrel in patients with acute coronary syndromesQ29619002
Representation of elderly persons and women in published randomized trials of acute coronary syndromesQ34331421
Clinical end points in coronary stent trials: a case for standardized definitionsQ36807166
Impact of pretreatment with clopidogrel on initial patency and outcome in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a systematic reviewQ37292941
Association of clopidogrel pretreatment with mortality, cardiovascular events, and major bleeding among patients undergoing percutaneous coronary intervention: a systematic review and meta-analysisQ38071527
Randomized assessment of ticagrelor versus prasugrel antiplatelet effects in patients with ST-segment-elevation myocardial infarctionQ38460956
Ticagrelor versus clopidogrel in patients with ST-elevation acute coronary syndromes intended for reperfusion with primary percutaneous coronary intervention: A Platelet Inhibition and Patient Outcomes (PLATO) trial subgroup analysisQ38497913
Impact of time from symptom onset to drug administration on outcome in patients undergoing glycoprotein IIb-IIIa facilitated primary angioplasty (from the EGYPT cooperation).Q38966136
Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trialsQ41187186
Inhibitory effects of ticagrelor compared with clopidogrel on platelet function in patients with acute coronary syndromes: the PLATO (PLATelet inhibition and patient Outcomes) PLATELET substudyQ42910350
2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice GuidelinesQ44265041
Door-to-balloon time and mortality among patients undergoing primary PCI.Q44655278
Comparison of ticagrelor, the first reversible oral P2Y(12) receptor antagonist, with clopidogrel in patients with acute coronary syndromes: Rationale, design, and baseline characteristics of the PLATelet inhibition and patient Outcomes (PLATO) triaQ46068914
Prasugrel versus clopidogrel in patients with acute coronary syndromesQ46915044
Impact of Escalating Loading Dose Regimens of Ticagrelor in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: Results of a Prospective Randomized Pharmacokinetic and Pharmacodynamic InvesQ52914499
Prehospital ticagrelor in ST-segment elevation myocardial infarction.Q53084786
Abciximab as Adjunctive Therapy to Reperfusion in Acute ST-Segment Elevation Myocardial InfarctionQ56944163
P433issue8
P407language of work or nameEnglishQ1860
P921main subjectclopidogrelQ410237
P304page(s)617-625
P577publication date2016-02-04
P1433published inHeartQ856338
P1476titleSafety and efficacy of ticagrelor and clopidogrel in primary percutaneous coronary intervention
P478volume102

Reverse relations

cites work (P2860)
Q55287536A Case of Atrioventricular Block Potentially Associated with Right Coronary Artery Lesion and Ticagrelor Therapy Mediated by the Increasing Adenosine Plasma Concentration.
Q39147735Antithrombotic therapy for patients with STEMI undergoing primary PCI.
Q49926557Cangrelor in Percutaneous Coronary Intervention: Current Status and Perspectives
Q91864154Changing Paradigms of Periprocedural Antithrombotic Therapy in Neuroendovascular Therapy: Analysis of JR-NET 3
Q55396201Comparative Review of Oral P2Y12 Inhibitors.
Q47744395Comparison of treatment outcomes of ticagrelor and clopidogrel among patients undergoing percutaneous coronary intervention: A meta-analysis
Q90464083Continuum of Care for Acute Coronary Syndrome: Optimizing Treatment for ST-Elevation Myocardial Infarction and Non-St-Elevation Acute Coronary Syndrome
Q38855389Current and novel approaches to treat patients presenting with ST elevation myocardial infarction
Q57143053De-Escalation of P2Y12 Receptor Inhibitor Therapy after Acute Coronary Syndromes in Patients Undergoing Percutaneous Coronary Intervention
Q64284677Guided de-escalation of DAPT in acute coronary syndrome patients undergoing percutaneous coronary intervention with BVS implantation: a post-hoc analysis from the randomized TROPICAL-ACS trial
Q92990016Impact of Preadmission Morphine on Reinfarction in Patients With ST-Elevation Myocardial Infarction Treated With Percutaneous Coronary Intervention: A Meta-Analysis
Q89563788LMU Munich: platelet inhibition novel aspects on platelet inhibition and function
Q41628280Pharmacokinetics and relative bioavailability of fixed-dose combination of clopidogrel and aspirin versus coadministration of individual formulations in healthy Korean men.
Q48512017Thrombosis and Vascular Inflammation in Diabetes: Mechanisms and Potential Therapeutic Targets

Search more.